| Open Document File Size: 803,17 KBShare Result on Facebook
Company Novartis Vaccines and Diagnostics Inc. / Novartis V&D Srl / Novartis Corporation / Novartis Vaccines and Diagnostics S.r.l. / / Country Italy / New Zealand / / Currency pence / / Event FDA Phase / / Facility Located In Building / Novartis Rosia Facility / New Hampshire Ave Building / Rosia Facility / Manufacturing Facility / / IndustryTerm drug product / residual product / biologic product / product contact equipment / degradation products / / MedicalCondition invasive meningococcal disease / invasive disease / / MedicalTreatment active immunization / / Organization Food and Drug Administration Center for Biologics Evaluation and Research / DEPARTMENT OF HEALTH AND HUMAN SERVICES / / Person Silver Spring / Carolyn Renshaw / Margaret Bash / Donald Ertel / Edward Wolfgang / / / Position Chair / OVRR/DBPAP / Branch Chief / General / Regulatory Officer / / Product eCTD / / ProvinceOrState Maryland / / PublishedMedium the Addendum Review / /
SocialTag |